ClinConnect ClinConnect Logo
Search / Trial NCT06231329

Role of Elastography in Diagnosis of Testicular Tumors

Launched by ALI MOHAMED ALAA EL-DIN · Jan 29, 2024

Trial Information

Current as of November 13, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to help doctors understand testicular tumors better using a special imaging technique called elastography. This method uses ultrasound to measure how stiff or soft a tumor is, which can help distinguish between different types of testicular tumors. The study will focus on men aged 15 to 65 who may have testicular pain or discomfort, or even those without any symptoms but have risk factors for testicular cancer.

If you're interested in participating, you would need to meet certain criteria, such as being within the age range and having a history of testicular pain or other related health issues. Participants will undergo an ultrasound elastography exam to assess the characteristics of their testicular lesions. The trial is currently not recruiting, so it’s still in the planning stages. If you have any questions about your eligibility or the study's details, it's best to speak with your healthcare provider.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • i. Age : (15-65 years).
  • ii. Patient with history of testicular pain or discomfort or even without clinical symptoms.
  • iii. Patient with any predisposing factors as mentioned before in the background.
  • iv. Patient with history of cancer of other organs (not testicular tumors).
  • Exclusion Criteria:
  • i. patient refused to be included in the study. ii. infarct correlation with patient history and symptoms is important. iii. Infections as focal orchitis. iv. History of trauma (hematoma exclusion).

About Ali Mohamed Alaa El Din

Ali Mohamed Alaa El-Din is a dedicated clinical trial sponsor with a focus on advancing medical research and improving patient outcomes. With a commitment to innovation and ethical standards, he oversees the design, implementation, and management of clinical trials across various therapeutic areas. His approach combines rigorous scientific methodology with a patient-centric perspective, ensuring that trials are conducted efficiently while prioritizing participant safety and well-being. Through collaboration with healthcare professionals and research institutions, Ali aims to contribute valuable insights to the medical community and support the development of groundbreaking therapies.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported